---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "MCOLgdjpAWWU/LDQz2G/WjTLX9/Kh3om7MmMGrrohMUSDY8Voz95XRU7PgjDdZ2uPVXjjIqP90XMrxYhH0dXMalcB3acDtNElea1PXT0ebr1HARcjj4D1awvL9FlgjlCNoyuogyqYPLXZLRMsiKehc/49nq4Hvy080n5O2iu1CTQW4yZ+j+GqKxm5vD86aJ5BiDHfWOSnR+z0GkashSPSgAisVKFAIS8APCIws0KcdsjI3kGcVzUoDZSAq8CXvhNs+ZSw/y9mAg4dg5hgXA2ZTJIProtJnzEI7ZvmB0Yy7OCEtaoVYWsTRIu0fVsX+/5JMi6598ucepxPM7E4QM8YQSEKSBdjoMs/bA3DL3H0nw=;0sgNtWzswUmEdUeMvI848A=="
---

